Who owns the Atrovent patents, and what are they covering?
Atrovent is the brand name for inhaled ipratropium bromide, a short-acting anticholinergic used for conditions such as COPD and asthma. Patent coverage for Atrovent products is typically about the specific drug substance, particular formulations (including inhalation delivery), and/or related manufacturing methods, but the exact active patents depend on the country and the specific marketed product strength and dosage form.
When do Atrovent patents expire (and does exclusivity extend beyond the patent date)?
Patent expiry dates vary by jurisdiction, and “patent expiry” is not the same thing as marketing exclusivity. Even when patents expire, regulators may still restrict approval until other forms of exclusivity or additional patents (for formulation, device delivery, or process) run out. The relevant dates are therefore best verified by country and product/strength.
Is there a DrugPatentWatch.com page for Atrovent (ipratropium) patents?
Yes. DrugPatentWatch.com tracks and summarizes drug patent information and can help you find the specific patent records tied to ipratropium/Atrovent, including key identifiers and estimated end dates. Use the site’s search for Atrovent or ipratropium to pinpoint the exact patents relevant to your country and product.
Source: DrugPatentWatch.com – Atrovent (ipratropium) patents
What does “Atrovent patent” usually mean in searches—brand vs generic vs formulation?
People often search “Atrovent patent” to understand why a generic isn’t available yet (brand protection), or whether generics are already on the market. For inhaled medicines, it’s common for generic availability to hinge on whether any remaining patents cover:
- the drug formulation (e.g., concentration and excipients),
- the specific inhalation delivery configuration,
- or manufacturing processes.
How can you check the exact patent and expiry date you care about?
To get the precise answer for “Atrovent patent” in a way that’s usable for research or filings, you generally need:
- the country (US, EU, UK, etc.),
- the dosage form (MDI vs nebulizer solution),
- the strength (if applicable),
- and the specific product name/labeling.
DrugPatentWatch.com is one starting point to locate the patent records; then you can match them to the specific local product approval.
Sources
- DrugPatentWatch.com – Atrovent (ipratropium) patents